These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4437701)
41. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Jackson JA; Jankovic J; Ford J Ann Neurol; 1983 Mar; 13(3):273-8. PubMed ID: 6847139 [TBL] [Abstract][Full Text] [Related]
42. [Progressive supranuclear paralysis]. Mozolevskiĭ IuV; Iakhno NN; Voznesenskaia TG; Kuuz RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):343-7. PubMed ID: 7395410 [No Abstract] [Full Text] [Related]
43. [Progressive supranuclear palsy: a clinical, natural history and disability study]. Macia F; Ballan G; Yekhlef F; Delmer O; Vital C; Lagueny A; Tison F Rev Neurol (Paris); 2003 Jan; 159(1):31-42. PubMed ID: 12618651 [TBL] [Abstract][Full Text] [Related]
44. [Progressive supranuclear palsy: a case report and etiological study of eye movement disturbance]. Kawamura Y; Shibazaki H; Shida K; Goto I; Kuroiwa Y Rinsho Shinkeigaku; 1975 Aug; 15(8):535-40. PubMed ID: 1237380 [No Abstract] [Full Text] [Related]
45. [Progressive supranuclear palsy following injury--a case report]. Wada S; Goya T; Matsukado Y Rinsho Shinkeigaku; 1976 Jul; 16(7):496-52. PubMed ID: 986920 [No Abstract] [Full Text] [Related]
46. Treatment of blepharospasm with levodopa. Chakravorty NK Postgrad Med J; 1974 Aug; 50(586):521-23. PubMed ID: 4464520 [No Abstract] [Full Text] [Related]
47. Progressive supranuclear palsy (the Steele-Richardson-Olszewski syndrome). A report of 9 cases with particular reference to the mechanism of the oculomotor disorder. Dix MR; Harrison MJ; Lewis PD J Neurol Sci; 1971 Jul; 13(3):237-56. PubMed ID: 5119443 [No Abstract] [Full Text] [Related]
48. Psychiatric aspects of progressive supranuclear palsy. Janati A; Appel AR J Nerv Ment Dis; 1984 Feb; 172(2):85-9. PubMed ID: 6693866 [TBL] [Abstract][Full Text] [Related]
53. [Steele-Richardson-Olszewski syndrome. Anatomo-pathologic study of a clinical case reported in 1966]. Kissel P; Floquet J; Andre JM; Thomas C; Craus A Rev Otoneuroophtalmol; 1977; 49(1):57-63. PubMed ID: 866880 [No Abstract] [Full Text] [Related]
55. Letter: Dimethyl aminoethanol in blepharospasm and hemifacial spasm. Dahdaleh MP; Small M; Thomas DJ N Engl J Med; 1975 Jul; 293(2):98. PubMed ID: 1168855 [No Abstract] [Full Text] [Related]
56. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Maher ER; Lees AJ Neurology; 1986 Jul; 36(7):1005-8. PubMed ID: 3714047 [TBL] [Abstract][Full Text] [Related]
57. Progressive supranuclear palsy. Case report with pathological findings. Anzil AP Acta Neuropathol; 1969 Sep; 14(1):72-6. PubMed ID: 5822040 [No Abstract] [Full Text] [Related]
58. Progressive supranuclear palsy: functional analysis of the response to methysergide and antiparkinsonian agents. Rafal RD; Grimm RJ Neurology; 1981 Dec; 31(12):1507-18. PubMed ID: 7198201 [TBL] [Abstract][Full Text] [Related]
59. [Progressive supranuclear paralysis. Nosologic framework and review. Apropos of an anatomo-clinical case]. Pons-Tortella E; Obach Cirera R; Galván Beramendi P; Reixach Casulá R Rev Clin Esp; 1982 Sep; 166(5):191-8. PubMed ID: 7146542 [No Abstract] [Full Text] [Related]
60. Contribution to clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy). On the distribution of neurofirbrillary tangles in the basal ganglia and brain-stem and its clinical significance. Ishino H; Ikeda H; Otsuki S J Neurol Sci; 1975 Apr; 24(4):471-81. PubMed ID: 1117315 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]